World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
28273
World Ranking
13167
National Ranking
1230

Overview

Noel W. Clarke is affiliated with the University of Salford in the United Kingdom. Their primary research is situated within the field of Medicine, with a focus on several subfields including Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery, and Cancer Research.

The core topics of their work center on Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications, PARP inhibition in cancer therapy, Cancer, Lipids, and Metabolism, Advanced Radiotherapy Techniques, and Bladder and Urothelial Cancer Treatments.

Prominent recent publications by Noel W. Clarke include:

  • "Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019" (2020), published in European Urology
  • "Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial" (2020), published in The Lancet
  • "Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer" (2022), published in NEJM Evidence
  • "Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial" (2023), published in The Lancet Oncology
  • "Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022" (2023), published in European Journal of Cancer

Noel W. Clarke frequently collaborates with several coauthors, including Nicholas D. James, Matthew R. Sydes, Jan van der Meulen, Julie Nossiter, and Ajay Aggarwal.

Their work is commonly published in venues such as European Urology, Journal of Clinical Oncology, Annals of Oncology, The Journal of Urology, and Radiotherapy and Oncology.

Best Publications

  • Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

    Nicholas D. James;Johann S. de Bono;Melissa R. Spears;Noel W. Clarke

  • Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

    Nicholas D. James;Nicholas D. James;Matthew R. Sydes;Noel W. Clarke;Malcolm David Mason

  • Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

    Christopher C Parker;Nicholas D James;Christopher D Brawley;Noel W Clarke

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

    Nicholas David James;Melissa R. Spears;Noel W. Clarke;David P. Dearnaley

  • Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

    Claire L. Vale;Sarah Burdett;Larysa H. M. Rydzewska;Laurence Albiges

  • Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

    Wanling Xie;Meredith M. Regan;Marc Buyse;Susan Halabi

  • Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.

    Noel Clarke;Pawel Wiechno;Boris Alekseev;Nuria Sala

  • Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

    N.W. Clarke;A. Ali;F.C. Ingleby;A. Hoyle

  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented]

    Silke Gillessen;Gerhardt Attard;Tomasz M. Beer;Himisha Beltran

  • Measurement of elastic properties of prostate cancer cells using AFM

    Elsa Correia Faria;Nan Ma;Ehsan Gazi;Peter Gardner

  • Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

    J Beyer;P Albers;R Altena;J Aparicio

  • Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

    Christopher C Parker;Noel W Clarke;Adrian D Cook;Howard G Kynaston

  • ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

    F Honecker;J Aparicio;D Berney;Jörg Beyer

  • A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer

    Joshua J. Meeks;Joaquim Bellmunt;Bernard H. Bochner;Noel W. Clarke

  • Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.

    Sarah Burdett;Liselotte M. Boevé;Fiona C. Ingleby;David J. Fisher

  • Morphometric evidence for bone resorption and replacement in prostate cancer.

    N. W. Clarke;J. McCLURE;N. J. R. George

  • Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

    M.R. Sydes;M.R. Spears;M.D. Mason;N.W. Clarke

  • Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

    Richard W Griffiths;Eyad Elkord;David E Gilham;Vijay A C Ramani

  • Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.

    Mark Morris;Christopher Ricketts;Dean Gentle;Fiona McRonald

Frequent Co-Authors

Nicholas D. James
Nicholas D. James Institute of Cancer Research
Matthew R. Sydes
Matthew R. Sydes University College London
Malcolm David Mason
Malcolm David Mason Cardiff University
David P. Dearnaley
David P. Dearnaley Institute of Cancer Research
Peter Gardner
Peter Gardner University of Manchester
Chris Parker
Chris Parker Institute of Cancer Research
Mahesh K. B. Parmar
Mahesh K. B. Parmar University College London
Jan van der Meulen
Jan van der Meulen University of London
Silke Gillessen
Silke Gillessen Universita della Svizzera Italiana
Gerhardt Attard
Gerhardt Attard University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to medicine in the USA can open up flexible and affordable career options for students. Many choose cheap rn to bsn programs to advance their nursing credentials quickly and cost-effectively. Such programs are designed for registered nurses seeking a Bachelor of Science in Nursing without the high cost or lengthy on-campus commitments.

If you already have a non-nursing bachelor’s degree, you may consider online direct entry msn programs for non-nurses. These accelerated pathways help prospective nurses leap into leadership or specialized roles, even if their undergraduate studies were in another field.

For students seeking accessible entry into nursing, direct entry nursing programs offer streamlined admissions and opportunities for those with diverse backgrounds or lower GPAs. These programs can be stepping stones to robust healthcare careers.

Not all medical careers require patient care. Administrative roles are also in demand, and medical billing and coding schools with financial aid allow you to enter the healthcare industry with flexible, affordable training—all from home.

Best Scientists Citing Noel W. Clarke

Trending Scientists

Recently Published Articles